Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8901777rdf:typepubmed:Citationlld:pubmed
pubmed-article:8901777lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8901777lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:8901777lifeskim:mentionsumls-concept:C0018791lld:lifeskim
pubmed-article:8901777lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:8901777pubmed:issue9 Suppllld:pubmed
pubmed-article:8901777pubmed:dateCreated1996-12-6lld:pubmed
pubmed-article:8901777pubmed:abstractTextThe cardioprotective role of adenosine in various models of ischemia-reperfusion, including adenosine supplementation to cardioplegic formulations, has been studied extensively. The appropriate dose of adenosine in humans is uncertain and could be limited by systemic hypotension or AV block.lld:pubmed
pubmed-article:8901777pubmed:languageenglld:pubmed
pubmed-article:8901777pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8901777pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8901777pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8901777pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8901777pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8901777pubmed:statusMEDLINElld:pubmed
pubmed-article:8901777pubmed:monthNovlld:pubmed
pubmed-article:8901777pubmed:issn0009-7322lld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:WalkerS ESElld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:GoldmanB SBSlld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:FremesS ESElld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:WongB IBIlld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:CohenE AEAlld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:ChristakisG...lld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:DeemarK AKAlld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:LevyS LSLlld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:Feder-ElituvR...lld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:IazettaJJlld:pubmed
pubmed-article:8901777pubmed:authorpubmed-author:MallidiH RHRlld:pubmed
pubmed-article:8901777pubmed:issnTypePrintlld:pubmed
pubmed-article:8901777pubmed:day1lld:pubmed
pubmed-article:8901777pubmed:volume94lld:pubmed
pubmed-article:8901777pubmed:ownerNLMlld:pubmed
pubmed-article:8901777pubmed:authorsCompleteYlld:pubmed
pubmed-article:8901777pubmed:paginationII370-5lld:pubmed
pubmed-article:8901777pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:meshHeadingpubmed-meshheading:8901777-...lld:pubmed
pubmed-article:8901777pubmed:year1996lld:pubmed
pubmed-article:8901777pubmed:articleTitlePhase 1 human trial of adenosine-potassium cardioplegia.lld:pubmed
pubmed-article:8901777pubmed:affiliationDepartment of Pharmacy, University of Toronto, Canada. Stephen.Fremes@sunnybrook.utoronto.calld:pubmed
pubmed-article:8901777pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8901777pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8901777pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:8901777pubmed:publicationTypeClinical Trial, Phase Illd:pubmed